0001104659-22-022712.txt : 20220214 0001104659-22-022712.hdr.sgml : 20220214 20220214160727 ACCESSION NUMBER: 0001104659-22-022712 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 EFFECTIVENESS DATE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qiming U.S. Ventures Management, LLC CENTRAL INDEX KEY: 0001909617 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-22101 FILM NUMBER: 22631634 BUSINESS ADDRESS: STREET 1: 11100 NE 8TH ST., SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 BUSINESS PHONE: (425) 709-0772 MAIL ADDRESS: STREET 1: 11100 NE 8TH ST., SUITE 200 CITY: BELLEVUE STATE: WA ZIP: 98004 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001909617 XXXXXXXX 12-31-2021 12-31-2021 false Qiming U.S. Ventures Management, LLC
11100 NE 8th St., Suite 200 Bellevue WA 98004
13F HOLDINGS REPORT 028-22101 N
Ryan Baker Chief Financial Officer 425-709-0772 /s/ Ryan Baker Bellevue WA 02-14-2022 0 6 217303 false
INFORMATION TABLE 2 a22-6602_2informationtable.xml INFORMATION TABLE ELEVATION ONCOLOGY INC COM 28623U101 14268 2370142 SH SOLE 2370142 0 0 ICOSAVAX INC COM 45114M109 80314 3510228 SH SOLE 3510228 0 0 JASPER THERAPEUTICS INC COM 471871103 45946 5852982 SH SOLE 5852982 0 0 KEZAR LIFE SCIENCES INC COM 49372L100 13856 828711 SH SOLE 828711 0 0 TALARIS THERAPEUTICS INC COM 87410C104 44840 2932606 SH SOLE 2932606 0 0 VENTYX BIOSCIENCES INC COM 92332V107 18079 910306 SH SOLE 910306 0 0